1. Home
  2. GNE vs EOLS Comparison

GNE vs EOLS Comparison

Compare GNE & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNE
  • EOLS
  • Stock Information
  • Founded
  • GNE 2011
  • EOLS 2012
  • Country
  • GNE United States
  • EOLS United States
  • Employees
  • GNE N/A
  • EOLS N/A
  • Industry
  • GNE Power Generation
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNE Utilities
  • EOLS Health Care
  • Exchange
  • GNE Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • GNE 419.3M
  • EOLS 493.5M
  • IPO Year
  • GNE N/A
  • EOLS 2018
  • Fundamental
  • Price
  • GNE $14.90
  • EOLS $6.63
  • Analyst Decision
  • GNE
  • EOLS Strong Buy
  • Analyst Count
  • GNE 0
  • EOLS 5
  • Target Price
  • GNE N/A
  • EOLS $21.25
  • AVG Volume (30 Days)
  • GNE 165.8K
  • EOLS 897.1K
  • Earning Date
  • GNE 11-05-2025
  • EOLS 11-05-2025
  • Dividend Yield
  • GNE 2.00%
  • EOLS N/A
  • EPS Growth
  • GNE 4.51
  • EOLS N/A
  • EPS
  • GNE 0.31
  • EOLS N/A
  • Revenue
  • GNE $456,876,000.00
  • EOLS $277,941,000.00
  • Revenue This Year
  • GNE $14.60
  • EOLS $14.01
  • Revenue Next Year
  • GNE $8.64
  • EOLS $29.46
  • P/E Ratio
  • GNE $48.74
  • EOLS N/A
  • Revenue Growth
  • GNE 3.75
  • EOLS 17.15
  • 52 Week Low
  • GNE $13.05
  • EOLS $5.71
  • 52 Week High
  • GNE $28.47
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • GNE 32.66
  • EOLS 34.55
  • Support Level
  • GNE $14.75
  • EOLS $7.19
  • Resistance Level
  • GNE $15.42
  • EOLS $7.58
  • Average True Range (ATR)
  • GNE 0.37
  • EOLS 0.32
  • MACD
  • GNE 0.21
  • EOLS -0.00
  • Stochastic Oscillator
  • GNE 20.78
  • EOLS 2.62

About GNE Genie Energy Ltd. Class B Stock

Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: